LEG
33
-2
DE
35
-3
FTI
71
2
HST
55
5
IR
79
7
NWL
23
4
GT
54
4
HOG
43
3
HCA
42
3
NTRS
32
2
VFC
17
2
PRGO
53
3
AMAT
54
4
GWW
62
4
PEG
48
-2
CMG
72
2
PAYX
53
2
HSIC
56
3
LEN
56
4
KLAC
56
3
LEG
33
-2
DE
35
-3
FTI
71
2
HST
55
5
IR
79
7
NWL
23
4
GT
54
4
HOG
43
3
HCA
42
3
NTRS
32
2
VFC
17
2
PRGO
53
3
AMAT
54
4
GWW
62
4
PEG
48
-2
CMG
72
2
PAYX
53
2
HSIC
56
3
LEN
56
4
KLAC
56
3
Financhill
Back

ProShares UltraShort Nasdaq Biotech Stock Predictions

Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!

Act now for your path to extra income!
Sell
40

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
19.86
Seasonality Move:
-13.57%

7 Day Trial

ALL ACCESS PASS

$ 7

This DeFi Coin Could 10x Soon... I Advise You Get In Now!

Discover this DeFi diamond before the next surge

ProShares UltraShort Nasdaq Biotech Stock Forecast

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotech has on average historically fallen by 27.6% based on the past 13 years of stock performance.
  • ProShares UltraShort Nasdaq Biotech has fallen lower in 10 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 76.92%
  • Is ProShares UltraShort Nasdaq Biotech Stock Undervalued?
    The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $19.94. The Score for BIS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will ProShares UltraShort Nasdaq Biotech Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotech has on average historically fallen by 27.6% based on the past 13 years of stock performance.

ProShares UltraShort Nasdaq Biotech Stock Rating

Sell
40
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech overpriced?

  • ProShares UltraShort Nasdaq Biotech has fallen lower in 10 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 76.92%

ProShares UltraShort Nasdaq Biotech Stock Price History

Is BIS stock going to rise?

  • The current trend is moderately bullish and BIS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
26.51
52-Week Low:
16.37

Prediction Charts

Market Cap:
0
Price in USD:
19.94
Volume:
6.12K
Beta:
-1.67

Technical Analysis

SMA50:
18.27
SMA100:
18.61
SMA200:
20.43
52-Wk Change:
5.5%

Stock Predictions

  • Is ProShares UltraShort Nasdaq Biotech stock public?
    Yes, ProShares UltraShort Nasdaq Biotech is a publicly traded company.
  • What is the ProShares UltraShort Nasdaq Biotech stock quote today?
    The ProShares UltraShort Nasdaq Biotech stock price is 19.94 USD today.
  • How to buy ProShares UltraShort Nasdaq Biotech stock online?
    You can buy ProShares UltraShort Nasdaq Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-4 18.17 19.05 19.10 18.17
Apr-5 19.03 18.87 19.03 18.71
Apr-8 18.80 18.83 18.83 18.80
Apr-9 18.60 18.38 18.60 18.38
Apr-10 19.00 19.01 19.21 18.94
Apr-11 18.91 18.79 18.91 18.63
Apr-12 19.04 19.59 19.74 19.04
Apr-15 19.52 20.05 20.11 19.52
Apr-16 20.07 20.32 20.32 20.05
Apr-17 20.25 20.57 20.57 20.22
Apr-18 20.67 20.98 20.98 20.54
Apr-19 20.90 20.90 21.10 20.87
Apr-22 20.74 20.48 20.74 20.13
Apr-23 20.24 19.94 20.24 19.71

ProShares UltraShort Nasdaq Biotech Earnings

Data Unavailable

ProShares UltraShort Nasdaq Biotech Forecast Revenue Growth

Data Unavailable

* ProShares UltraShort Nasdaq Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.